Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-075-7 | CAS number: 91-53-2
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- Peer-reviewed assessment report (attached in section 13)
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Version / remarks:
- US EPA FIFRA Guideline §81-1
- Deviations:
- yes
- Remarks:
- Purity of the test compound was not determined by the laboratory prior to conduct of the test
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not applicable
- GLP compliance:
- yes
- Remarks:
- self-certified to US EPA regulations at 40 CFR Parts 160 and 792
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Ethoxyquin
- EC Number:
- 202-075-7
- EC Name:
- Ethoxyquin
- Cas Number:
- 91-53-2
- Molecular formula:
- C14H19NO
- IUPAC Name:
- ethoxyquin
- Details on test material:
- Chemical name
IUPAC: 6-ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline
CAS: 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
Constituent 1
- Specific details on test material used for the study:
- clear reddish brown liquid
Test animals
- Species:
- rat
- Strain:
- other: albino rats (Crl:CD®BR)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc. Portage MI USA
- Age at study initiation: young
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.51 mL/kg
- Doses:
- 1500, 1950 and 2535 mg/kg bw
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- other: not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 726 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 675 mg/kg bw
- Based on:
- test mat.
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 779 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All deaths occurred within 3 days of dosing. Mortality was 2/10, 9/10 and 8/10 for the 1500, 1950 and 2535 mg/kg bw groups, respectively.
- Clinical signs:
- Clinical signs included ataxia in 24 animals, hypoactivity (21 rats), ocular discharge (16 rats), urogenital staining, hypothermia (cool to touch, 13 rats), dried red material around the eye(s), forelimb(s), and/or nose, laboured respiration (11 rats), prostrate positioning (10 rats), abnormal excretion (5 rats), and dried yellow material around the mouth. With the exception of dried yellow urogenital staining noted for two rats, all surviving animals appeared normal by day 7 or earlier and throughout the remainder of the study.
- Body weight:
- There were no remarkable changes in body weights for all animals.
- Gross pathology:
- Histopathological changes indicated an irritant effect on the gastrointestinal tract. Three animals had an hemorrhagic thymus gland. Two rats had dark red lungs and red fluid contents in the urinary bladder. One animal had enlarged cervical lymph nodes, and one had opacity in the right eye. There were no other gross necropsy findings neither in the animals that survived to the scheduled euthanisation nor in those that were found dead.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- As information was provided via a peer-reviewed assessment report, it can be considered as sufficiently reliable to assess the acute toxicity of ethoxyquin towards rats. Based on mortality data, an oral LD50 of 1779 mg/kg bw was calculated for male rats, of 1675 mg/kg bw for females, and of 1726 mg/kg bw for both sexes combined. Since the LD50 was below the limit of 2000 mg/kg bw, ethoxyquin shall be classified as being harmful if swallowed, i.e. acute toxic cat. 4 acc. to Regulation 1272/2008.
- Executive summary:
In an acute oral toxicity study (US EPA FIFRA Guideline §81-1, which is equivalent to OECD 401), groups of fasted, young adult albino rats (Crl:CD®BR)(5/sex/dose) were given a single oral dose ofneat ethoxyquinat doses of 1500, 1950 and 2535 mg/kg bw and observed for 14 days.
Oral LD50Males = 1779 mg/kg bw
Females = 1675 mg/kg bw
Combined = 1726 mg/kg bw
Ethoxyquin is of slight Toxicity based on the LD50 in females, and should be classified as acute toxic cat. 4.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
